• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗结核治疗后感染马红球菌与脓肿分枝杆菌肺病的 CT 表现对比

Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy.

机构信息

Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, Korea.

出版信息

Radiology. 2012 Apr;263(1):260-70. doi: 10.1148/radiol.12111374. Epub 2012 Feb 27.

DOI:10.1148/radiol.12111374
PMID:22371609
Abstract

PURPOSE

To present the serial computed tomographic (CT) findings of lung abnormalities in Mycobacterium massiliense pulmonary disease compared with those in Mycobacterium abscessus disease.

MATERIALS AND METHODS

The institutional review board approved this retrospective study and waived informed consent. Serial chest CT scans of M massiliense (n = 34) and M abscessus (n = 24) pulmonary diseases were retrospectively reviewed. Patients were treated with clarithromycin-containing combination antibiotics regimen, and sputum examinations were performed regularly. CT scans were obtained at the beginning of antibiotic therapy, at the end of 4-week hospitalization, and at the time of 12-month antibiotic therapy.

RESULTS

All patients with M massiliense disease had sputum conversion during treatment, whereas 50% of patients with M abscessus disease had sputum conversion. The most common CT findings of M massiliense disease at presentation were cellular bronchiolitis (n = 34, 100%), bronchiectasis (n = 34, 100%), consolidation (n = 33, 97%), nodules (n = 32, 94%), and cavities (n = 15, 44%). These findings were similar in M abscessus disease. Thirty (88%) patients with M massiliense disease had decrease in overall CT score at 12-month therapy, whereas only eight (33%) patients with M abscessus disease had a decrease (P < .0001). Improvement was noticeable in cellular bronchiolitis and cavity in M massiliense disease.

CONCLUSION

Common CT findings of M massiliense diseases overlap with those of M abscessus disease. However, responses to antibiotic treatment are much different; in M massiliense disease, negative sputum conversion is accomplished in all patients and serial CT scans show improvement in most patients.

摘要

目的

与脓肿分枝杆菌病相比,呈现分枝杆菌马萨里塞肺病的肺部异常连续计算机断层扫描(CT)表现。

材料与方法

该回顾性研究经机构审查委员会批准,并豁免了知情同意。回顾性分析了 34 例马萨里塞分枝杆菌和 24 例脓肿分枝杆菌肺病的连续胸部 CT 扫描。患者接受含克拉霉素的联合抗生素治疗方案治疗,定期进行痰检。CT 扫描分别在抗生素治疗开始时、4 周住院结束时和 12 个月抗生素治疗时进行。

结果

所有马萨里塞分枝杆菌病患者在治疗期间均发生痰培养转化,而脓肿分枝杆菌病患者中仅有 50%发生痰培养转化。马萨里塞分枝杆菌病的最常见 CT 表现为细胞性细支气管炎(n=34,100%)、支气管扩张(n=34,100%)、实变(n=33,97%)、结节(n=32,94%)和空洞(n=15,44%)。这些表现与脓肿分枝杆菌病相似。30 例(88%)马萨里塞分枝杆菌病患者在 12 个月治疗时的总 CT 评分下降,而脓肿分枝杆菌病患者中仅有 8 例(33%)评分下降(P<.0001)。马萨里塞分枝杆菌病患者的细胞性细支气管炎和空洞有明显改善。

结论

马萨里塞分枝杆菌病的常见 CT 表现与脓肿分枝杆菌病重叠。然而,抗生素治疗的反应却大不相同;在马萨里塞分枝杆菌病中,所有患者的痰培养均转为阴性,且连续 CT 扫描显示大多数患者均有改善。

相似文献

1
Serial CT findings of Mycobacterium massiliense pulmonary disease compared with Mycobacterium abscessus disease after treatment with antibiotic therapy.抗结核治疗后感染马红球菌与脓肿分枝杆菌肺病的 CT 表现对比
Radiology. 2012 Apr;263(1):260-70. doi: 10.1148/radiol.12111374. Epub 2012 Feb 27.
2
Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.从脓肿分枝杆菌中区分马赛分枝杆菌的临床意义。
Am J Respir Crit Care Med. 2011 Feb 1;183(3):405-10. doi: 10.1164/rccm.201003-0395OC. Epub 2010 Sep 10.
3
Computed tomographic findings of macrolide-resistant Mycobacterium massiliense pulmonary disease and changes after antibiotic treatment.大环内酯类耐药马西利亚分枝杆菌肺病的计算机断层扫描表现及抗生素治疗后的变化
Medicine (Baltimore). 2019 Sep;98(36):e16826. doi: 10.1097/MD.0000000000016826.
4
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense.脓肿分枝杆菌和马赛分枝杆菌肺病的进展和治疗结果。
Clin Infect Dis. 2017 Feb 1;64(3):301-308. doi: 10.1093/cid/ciw723. Epub 2016 Nov 10.
5
Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients.脓肿分枝杆菌肺病的抗生素治疗:65例患者的回顾性分析
Am J Respir Crit Care Med. 2009 Nov 1;180(9):896-902. doi: 10.1164/rccm.200905-0704OC. Epub 2009 Aug 6.
6
A shorter treatment duration may be sufficient for patients with Mycobacterium massiliense lung disease than with Mycobacterium abscessus lung disease.与脓肿分枝杆菌肺病患者相比,对马赛分枝杆菌肺病患者而言,较短的治疗疗程可能就足够了。
Respir Med. 2014 Nov;108(11):1706-12. doi: 10.1016/j.rmed.2014.09.002. Epub 2014 Sep 16.
7
Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients.比较囊性纤维化患者感染的马萨里隆分枝杆菌和脓肿分枝杆菌。
J Cyst Fibros. 2015 Jan;14(1):63-9. doi: 10.1016/j.jcf.2014.07.004. Epub 2014 Jul 30.
8
Oral Macrolide Therapy Following Short-term Combination Antibiotic Treatment of Mycobacterium massiliense Lung Disease.马赛分枝杆菌肺病短期联合抗生素治疗后的口服大环内酯类药物治疗
Chest. 2016 Dec;150(6):1211-1221. doi: 10.1016/j.chest.2016.05.003. Epub 2016 May 7.
9
Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.非结核分枝杆菌性眼部感染——脓肿分枝杆菌与马西利亚分枝杆菌临床及微生物学特征比较
PLoS One. 2015 Jan 12;10(1):e0116236. doi: 10.1371/journal.pone.0116236. eCollection 2015.
10
Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections.肺外脓肿分枝杆菌复合群感染的分枝杆菌学特征及治疗结果
Int J Infect Dis. 2017 Jul;60:49-56. doi: 10.1016/j.ijid.2017.05.007. Epub 2017 May 15.

引用本文的文献

1
Drug susceptibility profiles of isolated in the state of São Paulo, 2008-2024.2008年至2024年在圣保罗州分离出的菌株的药敏谱。
J Med Microbiol. 2025 Apr;74(4). doi: 10.1099/jmm.0.002005.
2
Tolerability and efficacy of Mycobacterium avium complex pulmonary disease treatment in elderly patients.老年鸟分枝杆菌复合群肺病治疗的耐受性和疗效
BMC Pulm Med. 2025 Feb 7;25(1):67. doi: 10.1186/s12890-025-03504-4.
3
Effectiveness of Amikacin liposome inhalation suspension for refractory Mycobacterium avium complex pulmonary disease at 6 months post initiation.
起始治疗 6 个月后,卷曲霉素脂质体吸入混悬液治疗耐多药鸟分枝杆菌复合群肺病的疗效。
BMC Pulm Med. 2024 Sep 10;24(1):442. doi: 10.1186/s12890-024-03261-w.
4
Significance of changes in cavity after treatment in Mycobacterium avium complex pulmonary disease.分枝杆菌复合群肺病治疗后空洞变化的意义。
Sci Rep. 2024 Sep 10;14(1):21133. doi: 10.1038/s41598-024-71971-6.
5
Nontuberculous mycobacterial pulmonary disease presenting as bronchiolitis pattern on CT without cavity or bronchiectasis.非结核分枝杆菌肺病 CT 表现为无空洞或支气管扩张的细支气管炎模式。
BMC Pulm Med. 2024 Sep 2;24(1):432. doi: 10.1186/s12890-024-03223-2.
6
Evaluation of treatment response with serial CT in patients with non-tuberculous mycobacterial pulmonary disease.非结核分枝杆菌肺病患者连续CT评估治疗反应
Eur Radiol. 2025 Feb;35(2):798-805. doi: 10.1007/s00330-024-10987-y. Epub 2024 Aug 1.
7
Usefulness of the mini nutritional assessment short-form for evaluating nutritional status in patients with nontuberculous mycobacterial pulmonary disease: a prospective cross-sectional study.用于评估非结核分枝杆菌肺病患者营养状况的微型营养评估简表的实用性:一项前瞻性横断面研究。
BMC Infect Dis. 2024 Jun 19;24(1):604. doi: 10.1186/s12879-024-09499-3.
8
CT findings as predictive factors for treatment failure in Mycobacterium abscessus complex lung disease: a retrospective cohort study.CT 表现作为预测分枝杆菌脓肿复合体肺病治疗失败的因素:一项回顾性队列研究。
Jpn J Radiol. 2024 Aug;42(8):852-861. doi: 10.1007/s11604-024-01570-y. Epub 2024 May 6.
9
Treatment Outcomes of Clofazimine-Containing Regimens in Severe Complex Pulmonary Disease.含氯法齐明方案治疗重症复杂肺部疾病的疗效
Open Forum Infect Dis. 2023 Dec 28;11(2):ofad682. doi: 10.1093/ofid/ofad682. eCollection 2024 Feb.
10
Myosteatosis as a prognostic factor of Mycobacterium avium complex pulmonary disease.肌肉脂肪浸润作为鸟分枝杆菌复合体肺病的预后因素。
Sci Rep. 2023 Aug 22;13(1):13680. doi: 10.1038/s41598-023-40984-y.